
Former GSK director joins Publicis Life Brands Resolute
pharmafile | October 22, 2013 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing | GSK, PLBR, publicis
Former director of branding and communications at GlaxoSmithKline Consumer Health Sian Dodwell, has joined Publicis Life Brands Resolute (PLBR) from Rapier.
Dodwell takes to PLBR 20 years of global integrated planning experience across healthcare and consumer sectors, working both agency and client side to lead development and deployment of brand building and communications strategies.
As well as her time at GSK Consumer Health and Rapier, Sian has previously worked at G2 Worldwide, Interfocus and The Architecture Foundation.
“Sian will lead our strategic planning offering to all of our clients across disciplines and her distinctive skill set and experience will add further depth to our strong senior team,” said Anna Korving, managing director at PLBR.
“Sian epitomises our ‘best and brightest’ approach to hiring and we are delighted to welcome her to our team.”
Related Content

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis
GSK’s Exdensur (depemokimab), a twice-yearly biological medicine, has received approval from the UK Medicines and …

Multiple myeloma treatment approved in Japan
GSK’s Blenrep (belantamab mafodotin) combinations have been approved by Japan’s Ministry of Health, Labour and …

US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit
PHILADELPHIA–GSK plc today announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) in combination …





